Erica Gomez

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study

Martin J. van den Bent, Hui Gan, Andrew B. Lassman et al. · Cancer Chemotherapy and Pharmacology · 2017 · 135 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma

David A. Reardon, Andrew B. Lassman, Martin J. van den Bent et al. · Neuro-Oncology · 2016 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with<i>EGFR</i>-amplified, recurrent glioblastoma: results from an international phase I multicenter trial

Andrew B. Lassman, Martin J. van den Bent, Hui Gan et al. · Neuro-Oncology · 2018 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma

Hui Gan, David A. Reardon, Andrew B. Lassman et al. · Neuro-Oncology · 2017 · 78 citations · Full text

Medicine, Oncology, Pharmacology +16

Characterization of nerve growth factor‐induced mechanical and thermal hypersensitivity in rats

Charles D. Mills, Timothy Nguyen, Flobert Tanga et al. · European Journal of Pain · 2012 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17